Alexandra N Bancos, Raul Gregg-Garcia, Natalia Genere, Sanan Mahrokhian, Sara J Achenbach, Elizabeth J Atkinson, Anand Vaidya, Irina Bancos
{"title":"Adrenal crises and quality of life after bilateral adrenalectomy vs primary autoimmune adrenal insufficiency.","authors":"Alexandra N Bancos, Raul Gregg-Garcia, Natalia Genere, Sanan Mahrokhian, Sara J Achenbach, Elizabeth J Atkinson, Anand Vaidya, Irina Bancos","doi":"10.1210/jendso/bvag104","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Bilateral adrenalectomy (BLA) and autoimmune adrenal insufficiency (AAI) are 2 major causes of primary adrenal insufficiency (PAI). Comparative data between etiologies are limited.</p><p><strong>Objective: </strong>To compare management, quality of life (QoL), and frequency of adrenal crises between participants post-BLA vs AAI.</p><p><strong>Methods: </strong>We conducted a dual-center, cross-sectional study of adults with AAI or BLA between 2018 and 2025. All participants completed questionnaires on management, adrenal crises, and the Addison Disease-specific QoL Questionnaire (AddiQoL).</p><p><strong>Results: </strong>Of 343 participants, 203 had AAI (median age 54 years, 72% women) and 139 had BLA (median age 57 years, 76% women). AddiQoL scores were similar between participants with AAI and BLA (median 84 vs 83, <i>P</i> = .947), but better in participants post-BLA for pheochromocytoma versus hypercortisolism (median 88 vs 81, <i>P</i> = .031). Participants with AAI reported a higher number of adrenal crises within the past year than those post-BLA (25% vs 13%, <i>P</i> = .022). In multivariable analyses of age, sex, glucocorticoid dose and type, PAI type, AddiQoL score, and autoimmune comorbidities, only PAI type was associated with higher number of reported adrenal crisis within the last year (AAI vs BLA: odds ratios of 2.1-2.2, <i>P</i> < .05 for all models).</p><p><strong>Conclusion: </strong>QoL was comparable between participants with AAI and BLA, though patients post-BLA for pheochromocytoma reported better QoL than patients post-BLA for hypercortisolism. Adrenal crises were more common in participants with AAI than those post-BLA, a finding that was not explained by patients' glucocorticoid management, underscoring the need for tailored crisis prevention strategies.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"10 8","pages":"bvag104"},"PeriodicalIF":4.4000,"publicationDate":"2026-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13376676/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvag104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Context: Bilateral adrenalectomy (BLA) and autoimmune adrenal insufficiency (AAI) are 2 major causes of primary adrenal insufficiency (PAI). Comparative data between etiologies are limited.
Objective: To compare management, quality of life (QoL), and frequency of adrenal crises between participants post-BLA vs AAI.
Methods: We conducted a dual-center, cross-sectional study of adults with AAI or BLA between 2018 and 2025. All participants completed questionnaires on management, adrenal crises, and the Addison Disease-specific QoL Questionnaire (AddiQoL).
Results: Of 343 participants, 203 had AAI (median age 54 years, 72% women) and 139 had BLA (median age 57 years, 76% women). AddiQoL scores were similar between participants with AAI and BLA (median 84 vs 83, P = .947), but better in participants post-BLA for pheochromocytoma versus hypercortisolism (median 88 vs 81, P = .031). Participants with AAI reported a higher number of adrenal crises within the past year than those post-BLA (25% vs 13%, P = .022). In multivariable analyses of age, sex, glucocorticoid dose and type, PAI type, AddiQoL score, and autoimmune comorbidities, only PAI type was associated with higher number of reported adrenal crisis within the last year (AAI vs BLA: odds ratios of 2.1-2.2, P < .05 for all models).
Conclusion: QoL was comparable between participants with AAI and BLA, though patients post-BLA for pheochromocytoma reported better QoL than patients post-BLA for hypercortisolism. Adrenal crises were more common in participants with AAI than those post-BLA, a finding that was not explained by patients' glucocorticoid management, underscoring the need for tailored crisis prevention strategies.
背景:双侧肾上腺切除术(BLA)和自身免疫性肾上腺功能不全(AAI)是原发性肾上腺功能不全(PAI)的两个主要原因。病因之间的比较数据有限。目的:比较bla与AAI后患者的管理、生活质量(QoL)和肾上腺危机发生频率。方法:我们对2018年至2025年间患有AAI或BLA的成人进行了一项双中心、横断面研究。所有参与者都完成了管理问卷、肾上腺危机问卷和Addison病特异性生活质量问卷(addqol)。结果:在343名参与者中,203名患有AAI(中位年龄54岁,72%为女性),139名患有BLA(中位年龄57岁,76%为女性)。AAI和BLA患者的AddiQoL评分相似(中位数84 vs 83, P = 0.947),但嗜铬细胞瘤患者BLA后的AddiQoL评分高于高皮质醇血症患者(中位数88 vs 81, P = 0.031)。与bla后相比,AAI患者在过去一年内报告的肾上腺危机数量更高(25% vs 13%, P = 0.022)。在年龄、性别、糖皮质激素剂量和类型、PAI类型、AddiQoL评分和自身免疫性合病的多变量分析中,只有PAI类型与去年报告的肾上腺危机数量较高相关(AAI与BLA:比值比为2.1-2.2,所有模型的P < 0.05)。结论:AAI和BLA患者的生活质量具有可比性,尽管嗜铬细胞瘤BLA后患者的生活质量优于高皮质醇血症BLA后患者。肾上腺危机在AAI患者中比bla后患者更常见,这一发现不能用患者的糖皮质激素管理来解释,强调了定制危机预防策略的必要性。